ID   CDK2_HUMAN              Reviewed;         298 AA.
AC   P24941; A8K7C6;
DT   01-MAR-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 2.
DT   02-NOV-2010, entry version 146.
DE   RecName: Full=Cell division protein kinase 2;
DE            EC=2.7.11.22;
DE   AltName: Full=p33 protein kinase;
GN   Name=CDK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=91330891; PubMed=1714386;
RA   Elledge S.J., Spottswood M.R.;
RT   "A new human p34 protein kinase, CDK2, identified by complementation
RT   of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of
RT   Xenopus Eg1.";
RL   EMBO J. 10:2653-2659(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=91367262; PubMed=1653904; DOI=10.1038/353174a0;
RA   Tsai L.-H., Harlow E., Meyerson M.;
RT   "Isolation of the human cdk2 gene that encodes the cyclin A- and
RT   adenovirus E1A-associated p33 kinase.";
RL   Nature 353:174-177(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=92020980; PubMed=1717994; DOI=10.1073/pnas.88.20.9006;
RA   Ninomiya-Tsuji J., Nomoto S., Yasuda H., Reed S.I., Matsumoto K.;
RT   "Cloning of a human cDNA encoding a CDC2-related kinase by
RT   complementation of a budding yeast cdc28 mutation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9006-9010(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-290.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PHOSPHORYLATION AT THR-14; TYR-15 AND THR-160, AND MUTAGENESIS OF
RP   THR-14; TYR-15 AND THR-160.
RX   MEDLINE=93010995; PubMed=1396589;
RA   Gu Y., Rosenblatt J., O'Morgan D.O.;
RT   "Cell cycle regulation of CDK2 activity by phosphorylation of Thr160
RT   and Tyr15.";
RL   EMBO J. 11:3995-4005(1992).
RN   [10]
RP   INTERACTION WITH CCNB3.
RX   PubMed=12185076; DOI=10.1074/jbc.M203951200;
RA   Nguyen T.B., Manova K., Capodieci P., Lindon C., Bottega S.,
RA   Wang X.-Y., Refik-Rogers J., Pines J., Wolgemuth D.J., Koff A.;
RT   "Characterization and expression of mammalian cyclin b3, a
RT   prepachytene meiotic cyclin.";
RL   J. Biol. Chem. 277:41960-41969(2002).
RN   [11]
RP   INTERACTION WITH SPDYA.
RX   PubMed=11980914; DOI=10.1083/jcb.200109045;
RA   Porter L.A., Dellinger R.W., Tynan J.A., Barnes E.A., Kong M.,
RA   Lenormand J.-L., Donoghue D.J.;
RT   "Human Speedy: a novel cell cycle regulator that enhances
RT   proliferation through activation of Cdk2.";
RL   J. Cell Biol. 157:357-366(2002).
RN   [12]
RP   INTERACTION WITH SPDYA.
RX   PubMed=12839962;
RA   Barnes E.A., Porter L.A., Lenormand J.-L., Dellinger R.W.,
RA   Donoghue D.J.;
RT   "Human Spy1 promotes survival of mammalian cells following DNA
RT   damage.";
RL   Cancer Res. 63:3701-3707(2003).
RN   [13]
RP   INTERACTION WITH SPDYA, AND IDENTIFICATION IN A COMPLEX WITH CDKN1B
RP   AND SPDYA.
RX   PubMed=12972555; DOI=10.1091/mbc.E02-12-0820;
RA   Porter L.A., Kong-Beltran M., Donoghue D.J.;
RT   "Spy1 interacts with p27Kip1 to allow G1/S progression.";
RL   Mol. Biol. Cell 14:3664-3674(2003).
RN   [14]
RP   INTERACTION WITH UHRF2, AND IDENTIFICATION IN A COMPLEX WITH UHRF2 AND
RP   CCNE1.
RX   PubMed=15178429; DOI=10.1016/j.bbrc.2004.04.190;
RA   Li Y., Mori T., Hata H., Homma Y., Kochi H.;
RT   "NIRF induces G1 arrest and associates with Cdk2.";
RL   Biochem. Biophys. Res. Commun. 319:464-468(2004).
RN   [15]
RP   PHOSPHORYLATION AT THR-160.
RX   PubMed=14597612; DOI=10.1074/jbc.M309995200;
RA   Liu Y., Wu C., Galaktionov K.;
RT   "p42, a novel cyclin-dependent kinase-activating kinase in mammalian
RT   cells.";
RL   J. Biol. Chem. 279:4507-4514(2004).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=15302935; DOI=10.1073/pnas.0404720101;
RA   Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,
RA   Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
RT   "Large-scale characterization of HeLa cell nuclear phosphoproteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
RN   [17]
RP   INTERACTION WITH SPDYA AND SPDYC.
RX   PubMed=15611625;
RA   Cheng A., Xiong W., Ferrell J.E. Jr., Solomon M.J.;
RT   "Identification and comparative analysis of multiple mammalian
RT   Speedy/Ringo proteins.";
RL   Cell Cycle 4:155-165(2005).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15 AND TYR-19, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15; TYR-19 AND
RP   THR-160, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15 AND SER-46, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-14; TYR-15; TYR-19;
RP   SER-46; THR-158 AND TYR-159, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-15 AND THR-160, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-6, AND MASS SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   MEDLINE=93288132; PubMed=8510751; DOI=10.1038/363595a0;
RA   de Bondt H.L., Rosenblatt J., Jancarik J., Jones H.D., Morgan D.O.,
RA   Kim S.-H.;
RT   "Crystal structure of cyclin-dependent kinase 2.";
RL   Nature 363:595-602(1993).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF COMPLEX WITH CYCLIN A.
RX   MEDLINE=95356811; PubMed=7630397; DOI=10.1038/376313a0;
RA   Jeffrey P.D., Russo A.A., Polyak K., Gibbs E., Hurwitz J.,
RA   Massague J., Pavletich N.P.;
RT   "Mechanism of CDK activation revealed by the structure of a cyclinA-
RT   CDK2 complex.";
RL   Nature 376:313-320(1995).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF COMPLEX WITG CKS1.
RX   MEDLINE=96182647; PubMed=8601310; DOI=10.1016/S0092-8674(00)81065-X;
RA   Bourne Y., Watson M.H., Hickey M.J., Holmes W., Rocque W., Reed S.I.,
RA   Tainer J.A.;
RT   "Crystal structure and mutational analysis of the human CDK2 kinase
RT   complex with cell cycle-regulatory protein CksHs1.";
RL   Cell 84:863-874(1996).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   MEDLINE=97075215; PubMed=8917641; DOI=10.1021/jm960402a;
RA   Schulze-Gahmen U., de Bondt H.L., Kim S.-H.;
RT   "High-resolution crystal structures of human cyclin-dependent kinase 2
RT   with and without ATP: bound waters and natural ligand as guides for
RT   inhibitor design.";
RL   J. Med. Chem. 39:4540-4546(1996).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF COMPLEX WITH CG2A AND KIP1.
RX   MEDLINE=96300318; PubMed=8684460; DOI=10.1038/382325a0;
RA   Russo A.A., Jeffrey P.D., Patten A.K., Massague J., Pavletich N.P.;
RT   "Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor
RT   bound to the cyclin A-Cdk2 complex.";
RL   Nature 382:325-331(1996).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF COMPLEX WITH CG2A.
RX   MEDLINE=96313126; PubMed=8756328; DOI=10.1038/nsb0896-696;
RA   Russo A.A., Jeffrey P.D., Pavletich N.P.;
RT   "Structural basis of cyclin-dependent kinase activation by
RT   phosphorylation.";
RL   Nat. Struct. Biol. 3:696-700(1996).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.33 ANGSTROMS) OF COMPLEX WITH L868276.
RX   MEDLINE=96181476; PubMed=8610110; DOI=10.1073/pnas.93.7.2735;
RA   de Azevedo W.F. Jr., Mueller-Dieckmann H.-J., Schulze-Gahmen U.,
RA   Worland P.J., Sausville E., Kim S.-H.;
RT   "Structural basis for specificity and potency of a flavonoid inhibitor
RT   of human CDK2, a cell cycle kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:2735-2740(1996).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   MEDLINE=97475219; PubMed=9334743; DOI=10.1038/nsb1097-796;
RA   Lawrie A.M., Noble M.E.M., Tunnah P., Brown N.R., Johnson L.N.,
RA   Endicott J.A.;
RT   "Protein kinase inhibition by staurosporine revealed in details of the
RT   molecular interaction with CDK2.";
RL   Nat. Struct. Biol. 4:796-801(1997).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS).
RX   MEDLINE=98342369; PubMed=9677190; DOI=10.1126/science.281.5376.533;
RA   Gray N.S., Wodicka L., Thunnissen A.-M.W.H., Norman T.C., Kwon S.,
RA   Espinoza F.H., Morgan D.O., Barnes G., Leclerc S., Meijer L.,
RA   Kim S.H., Lockhart D.J., Schultz P.G.;
RT   "Exploiting chemical libraries, structure, and genomics in the search
RT   for kinase inhibitors.";
RL   Science 281:533-538(1998).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 1-288 IN COMPLEX WITH CCNB1,
RP   AND FUNCTION.
RX   PubMed=17495531;
RA   Brown N.R., Lowe E.D., Petri E., Skamnaki V., Antrobus R.,
RA   Johnson L.N.;
RT   "Cyclin B and cyclin A confer different substrate recognition
RT   properties on CDK2.";
RL   Cell Cycle 6:1350-1359(2007).
RN   [36]
RP   VARIANTS [LARGE SCALE ANALYSIS] LEU-45 AND SER-290.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in the control of the cell cycle. Interacts
CC       with cyclins A, B1, B3, D, or E. Activity of CDK2 is maximal
CC       during S phase and G2.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Phosphorylation at Thr-14 or Tyr-15 inactivates
CC       the enzyme, while phosphorylation at Thr-160 activates it.
CC   -!- SUBUNIT: Found in a complex with CABLES1, CCNA1 and CCNE1.
CC       Interacts with CABLES1 (By similarity). Interacts with UHRF2. Part
CC       of a complex consisting of UHRF2, CDK2 and CCNE1. Interacts with
CC       the Speedy/Ringo proteins SPDYA and SPDYC. Found in a complex with
CC       both SPDYA and CDKN1B/KIP1.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-375096, EBI-375096;
CC       P49662:CASP4; NbExp=1; IntAct=EBI-375096, EBI-1057327;
CC       O95067:CCNB2; NbExp=1; IntAct=EBI-375096, EBI-375024;
CC       P24864:CCNE1; NbExp=4; IntAct=EBI-375096, EBI-519526;
CC       O96020:CCNE2; NbExp=5; IntAct=EBI-375096, EBI-375033;
CC       Q96Q40:CDK15; NbExp=1; IntAct=EBI-375096, EBI-1051975;
CC       P38936:CDKN1A; NbExp=5; IntAct=EBI-375096, EBI-375077;
CC       P46527:CDKN1B; NbExp=6; IntAct=EBI-375096, EBI-519280;
CC       Q16667:CDKN3; NbExp=1; IntAct=EBI-375096, EBI-1031527;
CC       P11171:EPB41; NbExp=1; IntAct=EBI-375096, EBI-1050906;
CC       Q9H1Q7:FAM113A; NbExp=1; IntAct=EBI-375096, EBI-748452;
CC       P22087:FBL; NbExp=1; IntAct=EBI-375096, EBI-358318;
CC       P25205:MCM3; NbExp=1; IntAct=EBI-375096, EBI-355153;
CC       Q14CX7:NAA25; NbExp=1; IntAct=EBI-375096, EBI-1048503;
CC       Q15843:NEDD8; NbExp=1; IntAct=EBI-375096, EBI-716247;
CC       O15294:OGT; NbExp=1; IntAct=EBI-375096, EBI-539828;
CC       Q13416:ORC2L; NbExp=1; IntAct=EBI-375096, EBI-374957;
CC       P30086:PEBP1; NbExp=1; IntAct=EBI-375096, EBI-716384;
CC       P62136:PPP1CA; NbExp=1; IntAct=EBI-375096, EBI-357253;
CC       P36873:PPP1CC; NbExp=1; IntAct=EBI-375096, EBI-356283;
CC       O75365:PTP4A3; NbExp=1; IntAct=EBI-375096, EBI-1043866;
CC       Q96JH8:RADIL; NbExp=1; IntAct=EBI-375096, EBI-744267;
CC       P06400:RB1; NbExp=1; IntAct=EBI-375096, EBI-491274;
CC       Q99523:SORT1; NbExp=1; IntAct=EBI-375096, EBI-1057058;
CC       Q15714:TSC22D1; NbExp=1; IntAct=EBI-375096, EBI-712609;
CC       P61081:UBE2M; NbExp=1; IntAct=EBI-375096, EBI-1041660;
CC       Q96PU4:UHRF2; NbExp=4; IntAct=EBI-375096, EBI-625304;
CC       P40337:VHL; NbExp=1; IntAct=EBI-375096, EBI-301246;
CC       Q9P2S5:WDR8; NbExp=1; IntAct=EBI-375096, EBI-1054904;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cdk2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X61622; CAA43807.1; -; mRNA.
DR   EMBL; X62071; CAA43985.1; -; mRNA.
DR   EMBL; M68520; AAA35667.1; -; mRNA.
DR   EMBL; BT006821; AAP35467.1; -; mRNA.
DR   EMBL; AF512553; AAM34794.1; -; Genomic_DNA.
DR   EMBL; AK291941; BAF84630.1; -; mRNA.
DR   EMBL; CH471054; EAW96858.1; -; Genomic_DNA.
DR   EMBL; BC003065; AAH03065.1; -; mRNA.
DR   IPI; IPI00031681; -.
DR   PIR; A41227; A41227.
DR   RefSeq; NP_001789.2; -.
DR   RefSeq; NP_439892.2; -.
DR   UniGene; Hs.19192; -.
DR   UniGene; Hs.689624; -.
DR   PDB; 1AQ1; X-ray; 2.00 A; A=1-298.
DR   PDB; 1B38; X-ray; 2.00 A; A=1-298.
DR   PDB; 1B39; X-ray; 2.10 A; A=1-298.
DR   PDB; 1BUH; X-ray; 2.60 A; A=1-298.
DR   PDB; 1CKP; X-ray; 2.05 A; A=1-298.
DR   PDB; 1DI8; X-ray; 2.20 A; A=1-298.
DR   PDB; 1DM2; X-ray; 2.10 A; A=1-298.
DR   PDB; 1E1V; X-ray; 1.95 A; A=1-298.
DR   PDB; 1E1X; X-ray; 1.85 A; A=1-298.
DR   PDB; 1E9H; X-ray; 2.50 A; A/C=1-296.
DR   PDB; 1F5Q; X-ray; 2.50 A; A/C=1-298.
DR   PDB; 1FIN; X-ray; 2.30 A; A/C=1-298.
DR   PDB; 1FQ1; X-ray; 3.00 A; B=1-298.
DR   PDB; 1FVT; X-ray; 2.20 A; A=1-298.
DR   PDB; 1FVV; X-ray; 2.80 A; A/C=1-298.
DR   PDB; 1G5S; X-ray; 2.61 A; A=1-298.
DR   PDB; 1GIH; X-ray; 2.80 A; A=1-298.
DR   PDB; 1GII; X-ray; 2.00 A; A=1-298.
DR   PDB; 1GIJ; X-ray; 2.20 A; A=1-298.
DR   PDB; 1GY3; X-ray; 2.70 A; A/C=1-296.
DR   PDB; 1GZ8; X-ray; 1.30 A; A=1-298.
DR   PDB; 1H00; X-ray; 1.60 A; A=1-298.
DR   PDB; 1H01; X-ray; 1.79 A; A=1-298.
DR   PDB; 1H07; X-ray; 1.85 A; A=1-298.
DR   PDB; 1H08; X-ray; 1.80 A; A=1-298.
DR   PDB; 1H0V; X-ray; 1.90 A; A=1-298.
DR   PDB; 1H0W; X-ray; 2.10 A; A=1-298.
DR   PDB; 1H1P; X-ray; 2.10 A; A/C=1-298.
DR   PDB; 1H1Q; X-ray; 2.50 A; A/C=1-298.
DR   PDB; 1H1R; X-ray; 2.00 A; A/C=1-298.
DR   PDB; 1H1S; X-ray; 2.00 A; A/C=1-298.
DR   PDB; 1H24; X-ray; 2.50 A; A/C=1-298.
DR   PDB; 1H25; X-ray; 2.50 A; A/C=1-298.
DR   PDB; 1H26; X-ray; 2.24 A; A/C=1-298.
DR   PDB; 1H27; X-ray; 2.20 A; A/C=1-298.
DR   PDB; 1H28; X-ray; 2.80 A; A/C=1-298.
DR   PDB; 1HCK; X-ray; 1.90 A; A=1-298.
DR   PDB; 1HCL; X-ray; 1.80 A; A=1-298.
DR   PDB; 1JST; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 1JSU; X-ray; 2.30 A; A=1-298.
DR   PDB; 1JSV; X-ray; 1.96 A; A=1-298.
DR   PDB; 1JVP; X-ray; 1.53 A; P=1-298.
DR   PDB; 1KE5; X-ray; 2.20 A; A=1-298.
DR   PDB; 1KE6; X-ray; 2.00 A; A=1-298.
DR   PDB; 1KE7; X-ray; 2.00 A; A=1-298.
DR   PDB; 1KE8; X-ray; 2.00 A; A=1-298.
DR   PDB; 1KE9; X-ray; 2.00 A; A=1-298.
DR   PDB; 1OGU; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 1OI9; X-ray; 2.10 A; A/C=1-298.
DR   PDB; 1OIQ; X-ray; 2.31 A; A=1-298.
DR   PDB; 1OIR; X-ray; 1.91 A; A=1-298.
DR   PDB; 1OIT; X-ray; 1.60 A; A=1-298.
DR   PDB; 1OIU; X-ray; 2.00 A; A/C=1-298.
DR   PDB; 1OIY; X-ray; 2.40 A; A/C=1-298.
DR   PDB; 1OKV; X-ray; 2.40 A; A/C=1-298.
DR   PDB; 1OKW; X-ray; 2.50 A; A/C=1-298.
DR   PDB; 1OL1; X-ray; 2.90 A; A/C=1-298.
DR   PDB; 1OL2; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 1P2A; X-ray; 2.50 A; A=1-298.
DR   PDB; 1P5E; X-ray; 2.22 A; A/C=1-298.
DR   PDB; 1PF8; X-ray; 2.51 A; A=1-298.
DR   PDB; 1PKD; X-ray; 2.30 A; A/C=1-296.
DR   PDB; 1PW2; X-ray; 1.95 A; A=1-298.
DR   PDB; 1PXI; X-ray; 1.95 A; A=1-298.
DR   PDB; 1PXJ; X-ray; 2.30 A; A=1-298.
DR   PDB; 1PXK; X-ray; 2.80 A; A=1-298.
DR   PDB; 1PXL; X-ray; 2.50 A; A=1-298.
DR   PDB; 1PXM; X-ray; 2.53 A; A=1-298.
DR   PDB; 1PXN; X-ray; 2.50 A; A=1-298.
DR   PDB; 1PXO; X-ray; 1.96 A; A=1-298.
DR   PDB; 1PXP; X-ray; 2.30 A; A=1-298.
DR   PDB; 1PYE; X-ray; 2.00 A; A=1-298.
DR   PDB; 1QMZ; X-ray; 2.20 A; A/C=1-298.
DR   PDB; 1R78; X-ray; 2.00 A; A=1-298.
DR   PDB; 1URC; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 1URW; X-ray; 1.60 A; A=1-298.
DR   PDB; 1V1K; X-ray; 2.31 A; A=1-298.
DR   PDB; 1VYW; X-ray; 2.30 A; A/C=1-298.
DR   PDB; 1VYZ; X-ray; 2.21 A; A=1-298.
DR   PDB; 1W0X; X-ray; 2.20 A; C=1-298.
DR   PDB; 1W8C; X-ray; 2.05 A; A=1-298.
DR   PDB; 1W98; X-ray; 2.15 A; A=1-297.
DR   PDB; 1WCC; X-ray; 2.20 A; A=1-298.
DR   PDB; 1Y8Y; X-ray; 2.00 A; A=1-298.
DR   PDB; 1Y91; X-ray; 2.15 A; A=1-298.
DR   PDB; 1YKR; X-ray; 1.80 A; A=1-298.
DR   PDB; 2A0C; X-ray; 1.95 A; X=1-298.
DR   PDB; 2A4L; X-ray; 2.40 A; A=1-298.
DR   PDB; 2B52; X-ray; 1.88 A; A=1-298.
DR   PDB; 2B53; X-ray; 2.00 A; A=1-298.
DR   PDB; 2B54; X-ray; 1.85 A; A=1-298.
DR   PDB; 2B55; X-ray; 1.85 A; A=1-298.
DR   PDB; 2BHE; X-ray; 1.90 A; A=1-298.
DR   PDB; 2BHH; X-ray; 2.60 A; A=1-298.
DR   PDB; 2BKZ; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 2BPM; X-ray; 2.40 A; A/C=1-298.
DR   PDB; 2BTR; X-ray; 1.85 A; A=1-298.
DR   PDB; 2BTS; X-ray; 1.99 A; A=1-298.
DR   PDB; 2C4G; X-ray; 2.70 A; A/C=1-298.
DR   PDB; 2C5N; X-ray; 2.10 A; A/C=1-298.
DR   PDB; 2C5O; X-ray; 2.10 A; A/C=1-298.
DR   PDB; 2C5V; X-ray; 2.90 A; A/C=1-298.
DR   PDB; 2C5X; X-ray; 2.90 A; A/C=1-298.
DR   PDB; 2C5Y; X-ray; 2.25 A; A=1-298.
DR   PDB; 2C68; X-ray; 1.95 A; A=1-298.
DR   PDB; 2C69; X-ray; 2.10 A; A=1-298.
DR   PDB; 2C6I; X-ray; 1.80 A; A=1-298.
DR   PDB; 2C6K; X-ray; 1.90 A; A=1-298.
DR   PDB; 2C6L; X-ray; 2.30 A; A=1-298.
DR   PDB; 2C6M; X-ray; 1.90 A; A=1-298.
DR   PDB; 2C6O; X-ray; 2.10 A; A=1-298.
DR   PDB; 2C6T; X-ray; 2.61 A; A/C=1-298.
DR   PDB; 2CCH; X-ray; 1.70 A; A/C=1-298.
DR   PDB; 2CCI; X-ray; 2.70 A; A/C=1-298.
DR   PDB; 2CJM; X-ray; 2.30 A; A/C=1-298.
DR   PDB; 2CLX; X-ray; 1.80 A; A=1-298.
DR   PDB; 2DS1; X-ray; 2.00 A; A=1-298.
DR   PDB; 2DUV; X-ray; 2.20 A; A=1-298.
DR   PDB; 2EXM; X-ray; 1.80 A; A=1-298.
DR   PDB; 2FVD; X-ray; 1.85 A; A=1-298.
DR   PDB; 2G9X; X-ray; 2.50 A; A/C=1-298.
DR   PDB; 2HIC; Model; -; A=1-298.
DR   PDB; 2I40; X-ray; 2.80 A; A/C=1-298.
DR   PDB; 2IW6; X-ray; 2.30 A; A/C=1-298.
DR   PDB; 2IW8; X-ray; 2.30 A; A/C=1-298.
DR   PDB; 2IW9; X-ray; 2.00 A; A/C=1-298.
DR   PDB; 2J9M; X-ray; 2.50 A; A=1-298.
DR   PDB; 2JGZ; X-ray; 2.90 A; A=1-288.
DR   PDB; 2R3F; X-ray; 1.50 A; A=1-298.
DR   PDB; 2R3G; X-ray; 1.55 A; A=1-298.
DR   PDB; 2R3H; X-ray; 1.50 A; A=1-298.
DR   PDB; 2R3I; X-ray; 1.28 A; A=1-298.
DR   PDB; 2R3J; X-ray; 1.65 A; A=1-298.
DR   PDB; 2R3K; X-ray; 1.70 A; A=1-298.
DR   PDB; 2R3L; X-ray; 1.65 A; A=1-298.
DR   PDB; 2R3M; X-ray; 1.70 A; A=1-298.
DR   PDB; 2R3N; X-ray; 1.63 A; A=1-298.
DR   PDB; 2R3O; X-ray; 1.80 A; A=1-298.
DR   PDB; 2R3P; X-ray; 1.66 A; A=1-298.
DR   PDB; 2R3Q; X-ray; 1.35 A; A=1-298.
DR   PDB; 2R3R; X-ray; 1.47 A; A=1-298.
DR   PDB; 2R64; X-ray; 2.30 A; A=1-298.
DR   PDB; 2UUE; X-ray; 2.06 A; A/C=1-298.
DR   PDB; 2UZB; X-ray; 2.70 A; A/C=1-298.
DR   PDB; 2UZD; X-ray; 2.72 A; A/C=1-298.
DR   PDB; 2UZE; X-ray; 2.40 A; A/C=1-298.
DR   PDB; 2UZL; X-ray; 2.40 A; A/C=1-298.
DR   PDB; 2UZN; X-ray; 2.30 A; A=1-298.
DR   PDB; 2UZO; X-ray; 2.30 A; A=1-298.
DR   PDB; 2V0D; X-ray; 2.20 A; A=1-298.
DR   PDB; 2V22; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 2VTA; X-ray; 2.00 A; A=1-298.
DR   PDB; 2VTH; X-ray; 1.90 A; A=1-298.
DR   PDB; 2VTI; X-ray; 2.00 A; A=1-298.
DR   PDB; 2VTJ; X-ray; 2.20 A; A=1-298.
DR   PDB; 2VTL; X-ray; 2.00 A; A=1-298.
DR   PDB; 2VTM; X-ray; 2.25 A; A=1-298.
DR   PDB; 2VTN; X-ray; 2.20 A; A=1-298.
DR   PDB; 2VTO; X-ray; 2.19 A; A=1-298.
DR   PDB; 2VTP; X-ray; 2.15 A; A=1-298.
DR   PDB; 2VTQ; X-ray; 1.90 A; A=1-298.
DR   PDB; 2VTR; X-ray; 1.90 A; A=1-298.
DR   PDB; 2VTS; X-ray; 1.90 A; A=1-298.
DR   PDB; 2VTT; X-ray; 1.68 A; A=1-298.
DR   PDB; 2VU3; X-ray; 1.85 A; A=1-298.
DR   PDB; 2VV9; X-ray; 1.90 A; A=1-298.
DR   PDB; 2W05; X-ray; 1.90 A; A=1-298.
DR   PDB; 2W06; X-ray; 2.04 A; A=1-298.
DR   PDB; 2W17; X-ray; 2.15 A; A=1-298.
DR   PDB; 2W1H; X-ray; 2.15 A; A=1-298.
DR   PDB; 2WEV; X-ray; 2.30 A; A/C=1-298.
DR   PDB; 2WFY; X-ray; 2.53 A; A/C=1-298.
DR   PDB; 2WHB; X-ray; 2.90 A; A/C=1-298.
DR   PDB; 2WIH; X-ray; 2.50 A; A/C=1-298.
DR   PDB; 2WIP; X-ray; 2.80 A; A/C=1-298.
DR   PDB; 2WMA; X-ray; 2.80 A; A/C=1-298.
DR   PDB; 2WMB; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 2WPA; X-ray; 2.51 A; A/C=1-298.
DR   PDB; 2WXV; X-ray; 2.60 A; A/C=1-298.
DR   PDB; 2X1N; X-ray; 2.75 A; A/C=1-298.
DR   PDB; 3BHT; X-ray; 2.00 A; A/C=1-298.
DR   PDB; 3BHU; X-ray; 2.30 A; A/C=1-298.
DR   PDB; 3BHV; X-ray; 2.10 A; A/C=1-298.
DR   PDB; 3DDP; X-ray; 2.70 A; A/C=1-298.
DR   PDB; 3DDQ; X-ray; 1.80 A; A/C=1-298.
DR   PDB; 3DOG; X-ray; 2.70 A; A/C=1-298.
DR   PDB; 3EID; X-ray; 3.15 A; A/C=1-298.
DR   PDB; 3EJ1; X-ray; 3.22 A; A/C=1-298.
DR   PDB; 3EOC; X-ray; 3.20 A; A/C=1-298.
DR   PDB; 3EZR; X-ray; 1.90 A; A=1-298.
DR   PDB; 3EZV; X-ray; 1.99 A; A=1-298.
DR   PDB; 3F5X; X-ray; 2.40 A; A/C=1-298.
DR   PDB; 3FZ1; X-ray; 1.90 A; A=1-298.
DR   PDB; 3IG7; X-ray; 1.80 A; A=1-298.
DR   PDB; 3IGG; X-ray; 1.80 A; A=1-298.
DR   PDB; 3LFN; X-ray; 2.28 A; A=1-298.
DR   PDB; 3LFQ; X-ray; 2.03 A; A=1-298.
DR   PDB; 3LFS; X-ray; 2.40 A; A=1-298.
DR   PDBsum; 1AQ1; -.
DR   PDBsum; 1B38; -.
DR   PDBsum; 1B39; -.
DR   PDBsum; 1BUH; -.
DR   PDBsum; 1CKP; -.
DR   PDBsum; 1DI8; -.
DR   PDBsum; 1DM2; -.
DR   PDBsum; 1E1V; -.
DR   PDBsum; 1E1X; -.
DR   PDBsum; 1E9H; -.
DR   PDBsum; 1F5Q; -.
DR   PDBsum; 1FIN; -.
DR   PDBsum; 1FQ1; -.
DR   PDBsum; 1FVT; -.
DR   PDBsum; 1FVV; -.
DR   PDBsum; 1G5S; -.
DR   PDBsum; 1GIH; -.
DR   PDBsum; 1GII; -.
DR   PDBsum; 1GIJ; -.
DR   PDBsum; 1GY3; -.
DR   PDBsum; 1GZ8; -.
DR   PDBsum; 1H00; -.
DR   PDBsum; 1H01; -.
DR   PDBsum; 1H07; -.
DR   PDBsum; 1H08; -.
DR   PDBsum; 1H0V; -.
DR   PDBsum; 1H0W; -.
DR   PDBsum; 1H1P; -.
DR   PDBsum; 1H1Q; -.
DR   PDBsum; 1H1R; -.
DR   PDBsum; 1H1S; -.
DR   PDBsum; 1H24; -.
DR   PDBsum; 1H25; -.
DR   PDBsum; 1H26; -.
DR   PDBsum; 1H27; -.
DR   PDBsum; 1H28; -.
DR   PDBsum; 1HCK; -.
DR   PDBsum; 1HCL; -.
DR   PDBsum; 1JST; -.
DR   PDBsum; 1JSU; -.
DR   PDBsum; 1JSV; -.
DR   PDBsum; 1JVP; -.
DR   PDBsum; 1KE5; -.
DR   PDBsum; 1KE6; -.
DR   PDBsum; 1KE7; -.
DR   PDBsum; 1KE8; -.
DR   PDBsum; 1KE9; -.
DR   PDBsum; 1OGU; -.
DR   PDBsum; 1OI9; -.
DR   PDBsum; 1OIQ; -.
DR   PDBsum; 1OIR; -.
DR   PDBsum; 1OIT; -.
DR   PDBsum; 1OIU; -.
DR   PDBsum; 1OIY; -.
DR   PDBsum; 1OKV; -.
DR   PDBsum; 1OKW; -.
DR   PDBsum; 1OL1; -.
DR   PDBsum; 1OL2; -.
DR   PDBsum; 1P2A; -.
DR   PDBsum; 1P5E; -.
DR   PDBsum; 1PF8; -.
DR   PDBsum; 1PKD; -.
DR   PDBsum; 1PW2; -.
DR   PDBsum; 1PXI; -.
DR   PDBsum; 1PXJ; -.
DR   PDBsum; 1PXK; -.
DR   PDBsum; 1PXL; -.
DR   PDBsum; 1PXM; -.
DR   PDBsum; 1PXN; -.
DR   PDBsum; 1PXO; -.
DR   PDBsum; 1PXP; -.
DR   PDBsum; 1PYE; -.
DR   PDBsum; 1QMZ; -.
DR   PDBsum; 1R78; -.
DR   PDBsum; 1URC; -.
DR   PDBsum; 1URW; -.
DR   PDBsum; 1V1K; -.
DR   PDBsum; 1VYW; -.
DR   PDBsum; 1VYZ; -.
DR   PDBsum; 1W0X; -.
DR   PDBsum; 1W8C; -.
DR   PDBsum; 1W98; -.
DR   PDBsum; 1WCC; -.
DR   PDBsum; 1Y8Y; -.
DR   PDBsum; 1Y91; -.
DR   PDBsum; 1YKR; -.
DR   PDBsum; 2A0C; -.
DR   PDBsum; 2A4L; -.
DR   PDBsum; 2B52; -.
DR   PDBsum; 2B53; -.
DR   PDBsum; 2B54; -.
DR   PDBsum; 2B55; -.
DR   PDBsum; 2BHE; -.
DR   PDBsum; 2BHH; -.
DR   PDBsum; 2BKZ; -.
DR   PDBsum; 2BPM; -.
DR   PDBsum; 2BTR; -.
DR   PDBsum; 2BTS; -.
DR   PDBsum; 2C4G; -.
DR   PDBsum; 2C5N; -.
DR   PDBsum; 2C5O; -.
DR   PDBsum; 2C5V; -.
DR   PDBsum; 2C5X; -.
DR   PDBsum; 2C5Y; -.
DR   PDBsum; 2C68; -.
DR   PDBsum; 2C69; -.
DR   PDBsum; 2C6I; -.
DR   PDBsum; 2C6K; -.
DR   PDBsum; 2C6L; -.
DR   PDBsum; 2C6M; -.
DR   PDBsum; 2C6O; -.
DR   PDBsum; 2C6T; -.
DR   PDBsum; 2CCH; -.
DR   PDBsum; 2CCI; -.
DR   PDBsum; 2CJM; -.
DR   PDBsum; 2CLX; -.
DR   PDBsum; 2DS1; -.
DR   PDBsum; 2DUV; -.
DR   PDBsum; 2EXM; -.
DR   PDBsum; 2FVD; -.
DR   PDBsum; 2G9X; -.
DR   PDBsum; 2HIC; -.
DR   PDBsum; 2I40; -.
DR   PDBsum; 2IW6; -.
DR   PDBsum; 2IW8; -.
DR   PDBsum; 2IW9; -.
DR   PDBsum; 2J9M; -.
DR   PDBsum; 2JGZ; -.
DR   PDBsum; 2R3F; -.
DR   PDBsum; 2R3G; -.
DR   PDBsum; 2R3H; -.
DR   PDBsum; 2R3I; -.
DR   PDBsum; 2R3J; -.
DR   PDBsum; 2R3K; -.
DR   PDBsum; 2R3L; -.
DR   PDBsum; 2R3M; -.
DR   PDBsum; 2R3N; -.
DR   PDBsum; 2R3O; -.
DR   PDBsum; 2R3P; -.
DR   PDBsum; 2R3Q; -.
DR   PDBsum; 2R3R; -.
DR   PDBsum; 2R64; -.
DR   PDBsum; 2UUE; -.
DR   PDBsum; 2UZB; -.
DR   PDBsum; 2UZD; -.
DR   PDBsum; 2UZE; -.
DR   PDBsum; 2UZL; -.
DR   PDBsum; 2UZN; -.
DR   PDBsum; 2UZO; -.
DR   PDBsum; 2V0D; -.
DR   PDBsum; 2V22; -.
DR   PDBsum; 2VTA; -.
DR   PDBsum; 2VTH; -.
DR   PDBsum; 2VTI; -.
DR   PDBsum; 2VTJ; -.
DR   PDBsum; 2VTL; -.
DR   PDBsum; 2VTM; -.
DR   PDBsum; 2VTN; -.
DR   PDBsum; 2VTO; -.
DR   PDBsum; 2VTP; -.
DR   PDBsum; 2VTQ; -.
DR   PDBsum; 2VTR; -.
DR   PDBsum; 2VTS; -.
DR   PDBsum; 2VTT; -.
DR   PDBsum; 2VU3; -.
DR   PDBsum; 2VV9; -.
DR   PDBsum; 2W05; -.
DR   PDBsum; 2W06; -.
DR   PDBsum; 2W17; -.
DR   PDBsum; 2W1H; -.
DR   PDBsum; 2WEV; -.
DR   PDBsum; 2WFY; -.
DR   PDBsum; 2WHB; -.
DR   PDBsum; 2WIH; -.
DR   PDBsum; 2WIP; -.
DR   PDBsum; 2WMA; -.
DR   PDBsum; 2WMB; -.
DR   PDBsum; 2WPA; -.
DR   PDBsum; 2WXV; -.
DR   PDBsum; 2X1N; -.
DR   PDBsum; 3BHT; -.
DR   PDBsum; 3BHU; -.
DR   PDBsum; 3BHV; -.
DR   PDBsum; 3DDP; -.
DR   PDBsum; 3DDQ; -.
DR   PDBsum; 3DOG; -.
DR   PDBsum; 3EID; -.
DR   PDBsum; 3EJ1; -.
DR   PDBsum; 3EOC; -.
DR   PDBsum; 3EZR; -.
DR   PDBsum; 3EZV; -.
DR   PDBsum; 3F5X; -.
DR   PDBsum; 3FZ1; -.
DR   PDBsum; 3IG7; -.
DR   PDBsum; 3IGG; -.
DR   PDBsum; 3LFN; -.
DR   PDBsum; 3LFQ; -.
DR   PDBsum; 3LFS; -.
DR   ProteinModelPortal; P24941; -.
DR   DIP; DIP-161N; -.
DR   IntAct; P24941; 122.
DR   MINT; MINT-96328; -.
DR   STRING; P24941; -.
DR   PhosphoSite; P24941; -.
DR   PRIDE; P24941; -.
DR   Ensembl; ENST00000266970; ENSP00000266970; ENSG00000123374.
DR   GeneID; 1017; -.
DR   KEGG; hsa:1017; -.
DR   UCSC; uc001sit.2; human.
DR   CTD; 1017; -.
DR   GeneCards; GC12P056360; -.
DR   H-InvDB; HIX0010710; -.
DR   HGNC; HGNC:1771; CDK2.
DR   HPA; CAB013115; -.
DR   MIM; 116953; gene.
DR   PharmGKB; PA101; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; P24941; -.
DR   OMA; LDLKKYM; -.
DR   OrthoDB; EOG95QKZV; -.
DR   PhylomeDB; P24941; -.
DR   BRENDA; 2.7.11.22; 247.
DR   Pathway_Interaction_DB; bard1pathway; BARD1 signaling events.
DR   Pathway_Interaction_DB; foxm1pathway; FOXM1 transcription factor network.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; smad2_3nuclearpathway; Regulation of nuclear SMAD2/3 signaling.
DR   Pathway_Interaction_DB; prlsignalingeventspathway; Signaling events mediated by PRL.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   Reactome; REACT_1538; Cell Cycle Checkpoints.
DR   Reactome; REACT_383; DNA Replication.
DR   BindingDB; P24941; -.
DR   NextBio; 4273; -.
DR   ArrayExpress; P24941; -.
DR   Bgee; P24941; -.
DR   CleanEx; HS_CDK2; -.
DR   Genevestigator; P24941; -.
DR   GermOnline; ENSG00000123374; Homo sapiens.
DR   GO; GO:0000307; C:cyclin-dependent protein kinase holoenzyme ...; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004693; F:cyclin-dependent protein kinase activity; EXP:Reactome.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006260; P:DNA replication; EXP:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:ProtInc.
DR   GO; GO:0007067; P:mitosis; IEA:UniProtKB-KW.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0007265; P:Ras protein signal transduction; IEP:BHF-UCL.
DR   GO; GO:0006275; P:regulation of DNA replication; TAS:ProtInc.
DR   GO; GO:0007089; P:traversing start control point of mitotic c...; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Cell cycle; Cell division;
KW   Complete proteome; Kinase; Mitosis; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    298       Cell division protein kinase 2.
FT                                /FTId=PRO_0000085769.
FT   DOMAIN        4    286       Protein kinase.
FT   NP_BIND      10     18       ATP.
FT   NP_BIND      81     83       ATP.
FT   NP_BIND     129    132       ATP.
FT   ACT_SITE    127    127       Proton acceptor.
FT   BINDING      33     33       ATP.
FT   BINDING      86     86       ATP.
FT   BINDING     145    145       ATP.
FT   MOD_RES       6      6       N6-acetyllysine.
FT   MOD_RES      14     14       Phosphothreonine.
FT   MOD_RES      15     15       Phosphotyrosine; by WEE1.
FT   MOD_RES      19     19       Phosphotyrosine.
FT   MOD_RES      46     46       Phosphoserine.
FT   MOD_RES     158    158       Phosphothreonine.
FT   MOD_RES     159    159       Phosphotyrosine.
FT   MOD_RES     160    160       Phosphothreonine; by CAK and CCRK.
FT   VARIANT      15     15       Y -> S (in dbSNP:rs3087335).
FT                                /FTId=VAR_016157.
FT   VARIANT      18     18       V -> L (in dbSNP:rs11554376).
FT                                /FTId=VAR_053927.
FT   VARIANT      45     45       P -> L (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041972.
FT   VARIANT     290    290       T -> S (in dbSNP:rs2069413).
FT                                /FTId=VAR_019988.
FT   MUTAGEN      14     14       T->A: 2-fold increase in activity.
FT   MUTAGEN      15     15       Y->F: 2-fold increase in activity.
FT   MUTAGEN     160    160       T->A: Abolishes activity.
FT   STRAND        4     12
FT   STRAND       14     23
FT   TURN         24     26
FT   STRAND       29     35
FT   HELIX        46     55
FT   STRAND       66     72
FT   STRAND       75     81
FT   STRAND       84     86
FT   HELIX        87     93
FT   TURN         94     97
FT   HELIX       101    120
FT   HELIX       130    132
FT   STRAND      133    135
FT   STRAND      141    143
FT   HELIX       148    152
FT   HELIX       171    174
FT   HELIX       183    198
FT   HELIX       208    219
FT   TURN        224    226
FT   HELIX       230    232
FT   HELIX       248    251
FT   HELIX       257    266
FT   TURN        271    273
FT   HELIX       277    281
FT   HELIX       284    286
SQ   SEQUENCE   298 AA;  33930 MW;  F90A0F4E70910B51 CRC64;
     MENFQKVEKI GEGTYGVVYK ARNKLTGEVV ALKKIRLDTE TEGVPSTAIR EISLLKELNH
     PNIVKLLDVI HTENKLYLVF EFLHQDLKKF MDASALTGIP LPLIKSYLFQ LLQGLAFCHS
     HRVLHRDLKP QNLLINTEGA IKLADFGLAR AFGVPVRTYT HEVVTLWYRA PEILLGCKYY
     STAVDIWSLG CIFAEMVTRR ALFPGDSEID QLFRIFRTLG TPDEVVWPGV TSMPDYKPSF
     PKWARQDFSK VVPPLDEDGR SLLSQMLHYD PNKRISAKAA LAHPFFQDVT KPVPHLRL
//
